🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

episode

The Biotech Startups Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

760 - Yellow Homebrew 59 min · 18 Sep 2026 · Not For Radio

NPR News: 09-17-2026 10PM EDT 4 min · 18 Sep 2026 · NPR News Now

10PM ET 09/17/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

Fans REACT To All Blacks Series LOSS In South Africa | Mailbag 25 min · 18 Sep 2026 · DSPN -RUGBY

Report any issue

Source

Recorded18 Nov 2024

Publisherfeeds.fame.so ↗

Handlerec:3386475

Show notes

Part 3 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to improve lives worldwide. With a PhD in Molecular and Cellular Pharmacology from Stony Brook University and over 25 years in drug discovery, Chris brings a wealth of experience. During his two-decade tenure at Eli Lilly, he advanced over 10 molecules into clinical trials across multiple therapeutic areas, spanning both small and large molecule modalities. Chris’s deep expertise and dedication to scientific innovation and team development offer invaluable insights for aspiring biotech leaders.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in